Clinical Trial Update: A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GW870086X for allergen challenge in mild asthmatics has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GW870086X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2018-02-20